Analystreport

Aralez Pharmaceuticals (NASDAQ: ARLZ) had its "buy" rating re-affirmed by analysts at Chardan Capital.

ARALEZ PHARMACEUTICALS INC COMMON SHARES  (ARLZ) 
Last aralez pharmaceuticals inc common shares earnings: 5/8 06:57 am Check Earnings Report
US:NASDAQ Investor Relations: aralez.com/investors